SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

SCHUTZ, Charlotte et al. Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa. SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.6, pp.507-511. ISSN 2078-5135.

    1. UNAIDS. World Aids Day Report. Berlin/Geneva: UNAIDS, 2011. unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_ en.pdf (accessed 3 January 2012). [ Links ]

    2. Motsoaledi A. How we're re-engineering the health system. Johannesburg: Politicsweb, 2011. politicsweb/en/page71656?oid=238984&sn=Detail&p id=71616 (accessed 14 November 2011). [ Links ]

    3. UNAIDS Republic of South Africa Country Progress Report on the Declaration of Commitment on HIV/AIDS. Berlin/Geneva: UNAIDS, 2010. progressreportssubmittedbycountries/ southafrica_2010_country_progress_report_ en.pdf (accessed 14 November 2011). [ Links ]

    4. WHO. Global Tuberculosis Control 2011. Geneva: WHO, 2011. global_report/2011/gtbr11_full.pdf (accessed 14 November 2011). [ Links ]

    5. Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis 2006;42(7):1040-1047. [ Links ]

    6. Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 2010;24(4):563-572. [ Links ]

    7. Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174(8):935-952. [ Links ]

    8. Montessori V, Press N, Harris M, Akagi L, Montaner JS. Adverse effects of antiretroviral therapy for HIV infection. CMAJ.2004;170(2):229-238. [ Links ]

    9. Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003;167(11):1472-1477. [ Links ]

    10. Tostmann A, Boeree MJ, Aarnoutse RE, et al. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008;23(2):192-202. [ Links ]

    11. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006;354(7):731-739. [ Links ]

    12. DAIDS. Table for Grading Adult and Pediatric Adverse Events. Version 1.0. 2004. _Severity_of_Adult_Pediatric_Adverse_Events.pdf (accessed 28 December 2011). [ Links ]

    13. Department of Health (DoH). National Tuberculosis Management Guidelines 2008. Pretoria: DoH, 2008. TBGUIDELINES2008SFINALFORPRINTINGMARCH09.pdf (accessed 28 December 2011). [ Links ]

    14. Department of Health. National Antiretroviral Treatment Guidelines. Johannesburg: Jacana, 2004. [ Links ]

    15. Nijland HM, L'Homme RF, Rongen GA, et al. High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets. AIDS 2008;22(8):931-935. [ Links ]

    16. Cohen K, Meintjes G. Management of individuals requiring antiretroviral therapy and TB treatment. Curr Opin HIV AIDS 2010;5(1):61-69. [ Links ]

    17. Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16(23):3041-3053. [ Links ]

    18. Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS One 2009;4(2):e4520. [ Links ]

    19. Hoffmann CJ, Charalambous S, Thio CL, et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS 2007;21(10):1301-1308. [ Links ]

    20. Pepper DJ, Marais S, Wilkinson RJ, et al. Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors. BMC Infect Dis 2010;10:83. [ Links ]